1. Be able to apply evidence-based surgical intervention for various stages and sites of head and neck cancer.
2. Be able to assess the role of adjuvant or definitive radiation therapy in the treatment of the above based on literature.
3. Be able to assess the role of chemotherapy use in the management of head and neck cancer in the neoadjuvant and concurrent radiotherapy settings.
12/29/2022 - 7:00am to 9:00am CST
Add to calendar:
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Participation
Daniel Haraf, MD